GlassScriptPhysician profile
Durga P Goli
NPI 1932165792
$13,821.85
in general payments reported to CMS, 2019-2025
43 companies · $1,325 in 2025
The $1,325 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,432 · 2020: $985 · 2021: $1,961 · 2022: $2,208 · 2023: $2,265 · 2024: $2,647 · 2025: $1,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,137 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,137.31 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,379.03 | 2019-2025 | |
| Amgen INC. | $2,239.25 | 2019-2025 | Evenity, Prolia, Otezla |
| Pfizer INC. | $1,221.03 | 2019-2025 | |
| Ucb, INC. | $967.19 | 2019-2025 | Cimzia, Bimzelx |
| Janssen Biotech, INC. | $816.24 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Astrazeneca Pharmaceuticals LP | $777.58 | 2021-2025 | Saphnelo |
| Glaxosmithkline, LLC. | $714.84 | 2019-2025 | Benlysta |
| E.R. Squibb & Sons, L.L.C. | $447.13 | 2019-2025 | Orencia |
| Radius Health, INC. | $354.09 | 2019-2024 | Tymlos |
| Sanofi-Aventis U.S. LLC | $287.61 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $237.18 | 2019-2025 | |
| Horizon Therapeutics Plc | $222.91 | 2019-2023 | Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.25 | 2023-2024 | Ofev, Cyltezo |
| Lifescan, INC. | $174.57 | 2021-2022 | |
| Novo Nordisk INC | $167.01 | 2020-2025 | Wegovy |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Durga Goli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.